Concepedia

Maureen C. Gammon

MC

9

Publications

472

Citations

9

H-Index

1988

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Maureen C. Gammon is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and clinical microbiology.

Top concepts

Publications per year

1988–1994

9

Publications

9

The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2

Maria A. Bednarek, Samir Sauma, Maureen C. Gammon et al. · The Journal of Immunology · 1991 · 208 citations

Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells

Hans J. Zweerink, Maureen C. Gammon, Ursula Utz et al. · The Journal of Immunology · 1993 · 94 citations

Mutation of the α2 domain disulfide bridge of the class I molecule HLA-A∗0201 Effect on maturation and peptide presentation

Robert Warburton, M. Matsui, Sarah Rowland‐Jones et al. · Human Immunology · 1994 · 47 citations

, , +8

Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa

Hans J. Zweerink, Maureen C. Gammon, Cameron F. Hutchison et al. · Infection and Immunity · 1988 · 43 citations · Full text

, , +21

Soluble HLA-A2.1 restricted peptides that are recognized by influenza virus specific cytotoxic T lymphocytes

Maria A. Bednarek, Sara A. Engl, Maureen C. Gammon et al. · Journal of Immunological Methods · 1991 · 20 citations

, , +5

Rows per page

1–5 of 9